France
Axorus, founded in 2019 and headquartered in France, is making strides in the Medical Devices industry with its innovative approach to ophthalmic technology. The company is focused on developing a novel Contact Lens designed to restore sight in individuals suffering from vision impairments such as dry Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP).
As a startup dedicating its efforts to address significant vision health challenges, Axorus has already captured the attention of the investor community, securing a substantial €368.00K Seed Round investment on 17 July 2020. This funding round was led by key investors including Nord France Amorcage, Finovam Gestion, and Happy Capital, showcasing strong confidence in the company's potential to impact the healthcare sector.
Overall, Axorus stands out as a promising venture poised to redefine treatment options for patients with degenerative eye diseases, offering a promising investment opportunity in the burgeoning field of medical technology.
